Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 509
interventional 332
Observational 147
Registry 30

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 133
Drug|placebo 72
Other 39
Device 22
Procedure 16
Behavioral 7
Drug|Procedure 6
Diagnostic Test 5
Radiation 4
Dietary Supplement 3
Behavioral|Drug 2
Behavioral|Other 2
Combination Product 2
Device|Drug 2
Device|Other 2
Drug|Other 2
Other|Procedure 2
Biological 1
Biological|Drug 1
Biological|placebo 1
Combination Product|placebo 1
Device|Procedure 1
Dietary Supplement|placebo 1
Drug|Other|placebo|Procedure 1
Drug|placebo|Procedure 1
Drug|Radiation 1
Other|Procedure|Radiation 1
placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 106
Switzerland 26
Germany 20
France 19
NA 16
China 12
United Kingdom 11
Canada 10
Austria 7
Japan 7
Egypt 6
Spain 5
Korea, Republic of 4
Turkey 4
United States|Puerto Rico 4
Belgium 3
Brazil 2
Indonesia 2
Israel 2
Mexico 2
Netherlands 2
Norway 2
United States|Australia|Austria|Belgium|Canada|Czech Republic|France|Germany|Italy|Netherlands|Poland|Spain|United Kingdom 2
United States|Australia|Canada 2
United States|Germany 2
Australia 1
Austria|Czechia|Germany|Poland 1
Austria|Germany 1
Belgium|Canada|Czechia|Egypt|Germany|Greece|Hungary|Israel|Italy|Netherlands|South Africa|Spain|Turkey 1
Belgium|China|Czechia|France|Germany|Hungary|Korea, Republic of|Lithuania|Mexico|Poland|Russian Federation|Switzerland|Thailand|Turkey|Ukraine|United Kingdom 1
Belgium|China|Czechia|France|Germany|Hungary|Lithuania|Mexico|Poland|Russian Federation|Switzerland|Thailand|Turkey|Ukraine|United Kingdom 1
Belgium|France|Italy|Netherlands|Poland|Portugal|Spain 1
Belgium|Israel|United Kingdom 1
Canada|United Kingdom 1
Colombia|Germany|Hungary|Italy|Japan|Mexico|Poland|Taiwan|Turkey 1
Czechia 1
France|Italy|Korea, Republic of|Poland|Thailand 1
Germany|United Kingdom 1
India 1
Israel|United States|Belgium|Canada|France|Germany|Italy|Netherlands|Portugal|Spain|Sweden|United Kingdom 1
Italy 1
Japan|United States|Australia|Austria|Belgium|Canada|France|Germany|Greece|Italy|Netherlands|Spain|Sweden|United Kingdom 1
Moldova, Republic of 1
Peru 1
Poland 1
Serbia 1
Taiwan|Turkey|United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Czech Republic|Denmark|France|Germany|Ireland|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Portugal|Russian Federation|Slovakia|Spain|Switzerland|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|China|Czechia|Denmark|Germany|Hungary|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Portugal|Russian Federation|Singapore|Slovakia|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Czech Republic|Denmark|France|Germany|Greece|Ireland|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Poland|Portugal|Russian Federation|Singapore|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Czechia|Denmark|France|Germany|Greece|Italy|Japan|Korea, Republic of|Mexico|Poland|Portugal|Russian Federation|Singapore|Sweden|Switzerland|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Czechia|Denmark|France|Germany|Israel|Italy|Japan|Korea, Republic of|Mexico|Poland|Portugal|Russian Federation|Slovakia|Spain|Switzerland|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|China|Croatia|Czechia|Denmark|France|Greece|Hungary|Israel|Italy|Korea, Republic of|Poland|Romania|Singapore|Spain|Sweden|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|China|Croatia|Czechia|Denmark|France|Greece|Hungary|Israel|Italy|Korea, Republic of|Poland|Romania|Singapore|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Czechia|Germany|Israel|Japan|Mexico|Netherlands|Philippines|Spain|United Kingdom 1
United States|Argentina|Australia|Brazil|Canada|Chile|Mexico|Russian Federation|Ukraine 1
United States|Argentina|France|Germany|Hungary|Italy|Japan|Russian Federation|Spain 1
United States|Australia|Austria|Belgium|Canada|China|Czech Republic|France|Germany|Italy|Netherlands|Spain|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|China|Czechia|Denmark|France|Germany|Italy|Japan|Netherlands|Poland|Singapore|Spain|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|France|Germany|Ireland|Israel|Italy|Netherlands|Poland|Spain|United Kingdom 1
United States|Australia|Belarus|Belgium|Brazil|Bulgaria|Canada|Colombia|Denmark|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Lithuania|Malaysia|Mexico|Poland|Portugal|Romania|Russian Federation|Serbia|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|Vietnam 1
United States|Australia|Belgium|Brazil|Czech Republic|Denmark|France|Germany|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|Norway|Poland|Singapore|South Africa|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|Brazil|Czech Republic|Denmark|France|Germany|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|Poland|Singapore|South Africa|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|France|Germany|Italy 1
United States|Australia|Brazil|Czech Republic|Hungary 1
United States|Austria|Belgium|Brazil|France|Germany|Israel|Italy|Japan|Mexico|Netherlands|Poland|Spain|Turkey 1
United States|Austria|Belgium|Canada|China|France|India|Israel|Italy|Mexico|Netherlands|Poland|Puerto Rico 1
United States|Austria|Belgium|Canada|Czechia|France|Germany|Israel|Italy|Spain|Switzerland 1
United States|Austria|Belgium|France|Germany|Ireland|Israel|Italy|Spain|United Kingdom 1
United States|Austria|Czech Republic|Germany|Italy|New Zealand|Poland|Spain|United Kingdom 1
United States|Belgium|Canada|Czech Republic|Denmark|France|Israel|Italy|Netherlands|Spain|United Kingdom 1
United States|Belgium|Canada|Czechia|France|Germany|Italy|Switzerland|United Kingdom 1
United States|Belgium|Canada|Denmark|France|Germany|Italy|Netherlands|Norway|Spain|Sweden|United Kingdom 1
United States|Belgium|Canada|France|Germany|Ireland|Italy|Japan|Spain|United Kingdom 1
United States|Belgium|Germany|Netherlands|Spain|United Kingdom 1
United States|Canada 1
United States|Canada|Netherlands 1
United States|France|Germany|United Kingdom 1
United States|France|Italy 1
United States|Germany|Spain 1

Sites per Study

Site_count Study_Count
1 207
2 18
3 9
4 5
5 4
6 6
7 5
8 5
9 4
10 3
11 3
13 2
15 2
16 6
17 2
18 2
19 1
21 1
22 1
23 2
25 3
27 1
30 2
31 1
32 2
33 1
34 1
36 1
38 1
39 1
42 1
43 2
46 2
50 1
51 2
52 1
56 1
58 1
59 1
62 1
65 1
68 1
72 1
73 1
77 1
83 1
93 1
96 1
97 1
99 1
102 1
126 1
130 1
131 1
143 1
177 1
178 1

Phase

Phase Study_Count
N/A 107
Phase 2 69
Phase 3 56
Phase 4 40
Phase 1 31
Phase 2/Phase 3 15
Phase 1/Phase 2 10
Early Phase 1 4

Number of Arms

Number_of_Arms Count_of_Studies
1 118
2 136
3 24
4 14
5 3
6 2
7 1
NA 34

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 6.00 6.00000 5.00000 9.00 4.00000 12.00000 8.0000 6.00000
1st Qu. 28.50 26.50000 13.50000 30.00 23.00000 26.00000 41.0000 11.50000
Median 55.50 30.00000 27.00000 51.00 40.00000 33.00000 154.0000 22.00000
Mean 229.25 94.48598 31.86667 67.10 54.86957 83.06667 197.9259 36.05128
3rd Qu. 256.25 88.50000 38.50000 110.75 70.00000 52.00000 273.0000 45.00000
Max. 800.00 2200.00000 120.00000 150.00 220.00000 326.00000 1000.0000 200.00000

Trial Group Type

group_type Group_Count
Experimental 308
Active Comparator 98
Placebo Comparator 93
NA 34
No Intervention 25
Other 23
Sham Comparator 5

Intervention Model

intervention_model Study_Count
Parallel Assignment 137
Single Group Assignment 133
Crossover Assignment 51
NA 6
Sequential Assignment 4
Factorial Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 226
Diagnostic 34
Prevention 32
Other 16
Basic Science 11
Supportive Care 5
Screening 3
NA 3
Device Feasibility 1
Educational/Counseling/Training 1

Observational Studies

Studies by Country

Country Study_Count
United States 50
Austria 10
NA 10
Germany 8
United Kingdom 7
China 6
France 6
Canada 5
Denmark 4
Italy 3
Japan 3
Egypt 2
Greece 2
Israel 2
Netherlands 2
Russian Federation 2
Switzerland 2
Argentina|Australia|Austria|Belgium|Canada|Colombia|Czechia|Denmark|Estonia|Finland|France|Germany|Greece|Ireland|Italy|Luxembourg|Netherlands|Norway|Portugal|Russian Federation|Saudi Arabia|Slovakia|Spain|Sweden|Switzerland|Taiwan|Turkey|United Kingdom 1
Australia|Belgium|Canada|Czech Republic|Denmark|France|Germany|Greece|Italy|Netherlands|Norway|Slovakia|Spain|Sweden|United Kingdom 1
Austria|Germany|Switzerland 1
Belgium|Canada|Colombia|Germany|Japan|Sweden|Turkey 1
Belgium|Germany|Ireland|Italy|Switzerland 1
France|Belgium 1
France|Germany|Italy|Portugal|Spain|United Kingdom 1
Germany|Switzerland 1
Kazakhstan|Kyrgyzstan|Lebanon|Russian Federation|Saudi Arabia|Turkey 1
Korea, Republic of 1
Kyrgyzstan 1
Mali 1
Nigeria 1
Norway 1
Poland 1
Portugal 1
Spain 1
Taiwan 1
Turkey 1
United States|Brazil 1
United States|Canada 1
United States|Canada|Ireland|United Kingdom 1
United States|Russian Federation 1

Sites per Study

Site_count Study_Count
1 114
2 13
3 1
4 2
5 3
6 1
7 2
8 2
9 1
13 1
14 1
23 1
25 1
28 1
43 1
54 1
113 1

Enrollment Metrics

Measure Observational
Min 1.0000
1st Qu 42.5000
Median 100.0000
Mean 556.0694
3rd Qu 322.2500
Max 19000.0000

Observation Model

observational_model Study_Count
Cohort 77
Case-Only 20
NA 17
Case-Control 15
Other 11
Case Control 6
Case-Crossover 1

Time Perspective

time_perspective Study_Count
Prospective 95
Cross-Sectional 22
Retrospective 18
NA 6
Other 5
Longitudinal, Prospective 1

Registries

Studies by Country

Country Study_Count
Kyrgyzstan 4
China 3
Germany 3
United States 3
NA 2
Poland 2
Belgium|Netherlands|Poland 1
Denmark|Norway|Sweden 1
Hong Kong 1
Netherlands 1
South Africa 1
Sweden 1
Switzerland 1
Taiwan 1
Turkey 1
United States|Australia|Austria|Belgium|Brazil|Canada|Denmark|Egypt|Finland|Germany|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Slovakia|Spain|Switzerland|Taiwan|Turkey|United Kingdom 1
United States|Australia|Brazil|Canada|China|Colombia|France|Germany|Hungary|Israel|Italy|Japan|Mexico|Netherlands|Poland|Saudi Arabia|Sweden|Switzerland 1
United States|Austria|Belgium|Czechia|France|Germany|Japan|Netherlands|Poland|United Kingdom 1
United States|Canada 1

Sites per Study

Site_count Study_Count
1 21
2 2
5 1
8 2
18 1
32 1
38 1
52 1

Enrollment Metrics

Measure Registries
Min 40.0000
1st Qu 173.0000
Median 227.0000
Mean 936.1667
3rd Qu 844.7500
Max 10000.0000

Registry Model

observational_model Study_Count
Cohort 24
Case-Control 4
Case-Only 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 27
Other 2
Cross-Sectional 1

Follow-up

target_duration Study_Count
5 Years 6
2 Years 5
3 Years 3
4 Years 3
1 Day 2
10 Years 2
3 Days 2
1 Week 1
1 Year 1
18 Months 1
20 Years 1
21 Days 1
4 Months 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03365479 Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT03365479 Completed University of Giessen 2018-08-01
NCT03385733 Inspiratory Muscle Training in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03385733 Completed Istanbul University 2018-02-15
NCT04193046 A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH) https://ClinicalTrials.gov/show/NCT04193046 Recruiting Janssen Research & Development, LLC 2021-03-31
NCT04175600 A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT04175600 Recruiting Janssen Research & Development, LLC 2024-12-09
NCT03980717 Fetal Endotracheal Occlusion (FETO) in the Resolution of Pulmonary Hypertension in Fetuses With Severe CDH https://ClinicalTrials.gov/show/NCT03980717 Recruiting Baylor College of Medicine 2028-12-31
NCT03629340 Metformin for Pulmonary Hypertension HFpEF https://ClinicalTrials.gov/show/NCT03629340 Recruiting University of Pittsburgh 2023-06-30
NCT03402191 L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03402191 Recruiting Tanta University 2023-12-31
NCT03399604 Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil https://ClinicalTrials.gov/show/NCT03399604 Active, not recruiting Liquidia Technologies, Inc. 2019-05-06
NCT03470207 The Prospective Risk Factor Evaluation & Discovery In CTEPH Study https://ClinicalTrials.gov/show/NCT03470207 Recruiting Intermountain Health Care, Inc. 2021-05-31
NCT03345212 A Randomized Controlled Multicenter Trial of Exercise Training in Pulmonary Hypertension in European Countries https://ClinicalTrials.gov/show/NCT03345212 Completed Heidelberg University 2018-12-31
NCT03273387 The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT03273387 Completed Indonesia University 2018-11-01
NCT03273257 Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study) https://ClinicalTrials.gov/show/NCT03273257 Recruiting International CTEPH Association 2020-07-31
NCT03270332 Effect of Inhaled Albuterol in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03270332 Recruiting University of Miami 2021-03-31
NCT03267108 A Safety and Efficacy Study of Pulsed Inhaled Nitric Oxide in Pulmonary Hypertension Associated With Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT03267108 Active, not recruiting Bellerophon 2022-06-16
NCT03205085 Determinants of Right Heart Remodeling in Patients With CTEPH or PAH https://ClinicalTrials.gov/show/NCT03205085 Recruiting Centre Chirurgical Marie Lannelongue 2020-07-01
NCT03197792 Perioperative Portal Vein Pulsatility as a Postoperative Prognostic Indicator in Pulmonary Endarterectomy https://ClinicalTrials.gov/show/NCT03197792 Recruiting Centre Chirurgical Marie Lannelongue 2018-05-24
NCT03194438 Urban Zen Integrative Therapy for Persons With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03194438 Completed Ohio State University 2018-06-05
NCT03186092 Effects of Training in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03186092 Recruiting Faculdade de Ciências Médicas da Santa Casa de São Paulo 2018-03-01
NCT03185364 The Safety and Efficiency of Sildenafil in the Treatment of Severe Post-capillary Pulmonary Hypertension Caused by COPD https://ClinicalTrials.gov/show/NCT03185364 Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital 2020-12-31
NCT03177603 A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH) https://ClinicalTrials.gov/show/NCT03177603 Completed GlaxoSmithKline 2019-05-07
NCT03122730 VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPB https://ClinicalTrials.gov/show/NCT03122730 Completed Aerogen Pharma Limited 2019-03-01
NCT03092622 Aerobic Interval Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Hypoxemia https://ClinicalTrials.gov/show/NCT03092622 Completed Norwegian University of Science and Technology 2019-12-31
NCT03077139 Cardiac Resynchronization Therapy in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03077139 Completed Ochsner Health System 2017-03-23
NCT03074539 Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03074539 Recruiting Medical University of Vienna 2020-02-01
NCT03068130 Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER https://ClinicalTrials.gov/show/NCT03068130 Active, not recruiting Reata Pharmaceuticals, Inc. 2021-12-31
NCT03044314 Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03044314 Recruiting Duke University 2020-12-01
NCT03022851 The Prophet Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03022851 Recruiting Occlutech International AB 2020-08-31
NCT03015402 Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction https://ClinicalTrials.gov/show/NCT03015402 Active, not recruiting University of Pittsburgh 2021-03-31
NCT03001414 Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs https://ClinicalTrials.gov/show/NCT03001414 Recruiting Northern Therapeutics 2020-10-31
NCT02963597 Auto-PAP for Pulmonary Hypertension Treatment in Decompensated HF Patients With Sleep Apnea. https://ClinicalTrials.gov/show/NCT02963597 Completed Albert Einstein Healthcare Network 2017-08-31
NCT02951130 Milrinone in Congenital Diaphragmatic Hernia https://ClinicalTrials.gov/show/NCT02951130 Recruiting NICHD Neonatal Research Network 2021-02-28
NCT02951104 Noninvasive Cardiac Output Monitoring in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02951104 Active, not recruiting Santa Barbara Cottage Hospital 2020-06-30
NCT02892981 Dead Space Evaluation in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02892981 Completed Centro Cardiologico Monzino 2016-01-31
NCT02886793 Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects https://ClinicalTrials.gov/show/NCT02886793 Completed Hospital Clinic of Barcelona 2018-07-31
NCT02885116 Effect of Nasal Highflow on Right Heart Function https://ClinicalTrials.gov/show/NCT02885116 Completed University of Leipzig 2018-02-28
NCT02859194 The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients https://ClinicalTrials.gov/show/NCT02859194 Completed Yonsei University 2016-10-14
NCT02844036 Angioplasty of Distal Lesions for Carriers of Inoperable Post-embolic HTP https://ClinicalTrials.gov/show/NCT02844036 Completed University Hospital, Grenoble 2017-10-31
NCT02835950 TReatment Of Pulmonary HYpertension 1-US Study https://ClinicalTrials.gov/show/NCT02835950 Active, not recruiting SoniVie Ltd. 2019-04-20
NCT02829034 Targeting Right Ventricle in Pulmonary Hypertension Gilead https://ClinicalTrials.gov/show/NCT02829034 Completed University of Pennsylvania 2017-12-31
NCT02755298 Chronic Clinical Effect of Acetazolamide https://ClinicalTrials.gov/show/NCT02755298 Recruiting University of Zurich 2020-06-30
NCT02755259 Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02755259 Completed University of Zurich 2019-04-05
NCT02742909 Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease https://ClinicalTrials.gov/show/NCT02742909 Completed Shengjing Hospital 2018-12-31
NCT02712294 Impact of NMES on Spirometry Values, Functional Capacity and Quality of Life in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02712294 Completed Faculdade de Ciências Médicas da Santa Casa de São Paulo 2016-06-30
NCT02688387 A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects https://ClinicalTrials.gov/show/NCT02688387 Completed GlaxoSmithKline 2017-08-04
NCT02661802 Effects Oxygen Supplementation Determined Better Exercise Capacity in Eisenmenger Syndrome https://ClinicalTrials.gov/show/NCT02661802 Completed Federal University of São Paulo 2014-06-30
NCT02651272 Macitentan in Pulmonary Hypertension of Sickle Cell Disease https://ClinicalTrials.gov/show/NCT02651272 Completed Boston University 2019-12-18
NCT02633293 An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE https://ClinicalTrials.gov/show/NCT02633293 Active, not recruiting United Therapeutics 2022-11-30
NCT02630316 Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE https://ClinicalTrials.gov/show/NCT02630316 Completed United Therapeutics 2019-12-26
NCT02595541 Oral Sildenafil and Intravenous Milrinone on Postoperative Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02595541 Completed Assiut University 2015-10-31
NCT02587325 ABI-009, an mTOR Inhibitor, for Patients With Severe Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT02587325 Recruiting Aadi, LLC 2020-12-31
NCT03926572 Acute Decompensation of Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03926572 Recruiting Assistance Publique - Hôpitaux de Paris 2021-06-01
NCT03626688 A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients https://ClinicalTrials.gov/show/NCT03626688 Recruiting United Therapeutics 2021-12-31
NCT01757782 Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns https://ClinicalTrials.gov/show/NCT01757782 Completed Sir Takhtasinhji General Hospital 2012-08-31
NCT02980068 A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction https://ClinicalTrials.gov/show/NCT02980068 Recruiting University of Pittsburgh 2021-01-31
NCT02759419 A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension. https://ClinicalTrials.gov/show/NCT02759419 Recruiting Bayer 2023-12-28
NCT02562235 Riociguat in Children With Pulmonary Arterial Hypertension (PAH) https://ClinicalTrials.gov/show/NCT02562235 Active, not recruiting Bayer 2020-03-07
NCT02558582 Effect of Exercise Training in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02558582 Recruiting University of Zurich 2020-12-31
NCT02554903 Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation https://ClinicalTrials.gov/show/NCT02554903 Completed Actelion 2020-03-13
NCT02551653 Positron Emission Tomography (PET) Study to Evaluate Biodistribution of [11C]-GSK2256098 in Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patients https://ClinicalTrials.gov/show/NCT02551653 Completed GlaxoSmithKline 2017-03-14
NCT02516722 TReatment Of Pulmonary HYpertension 1 Study https://ClinicalTrials.gov/show/NCT02516722 Active, not recruiting SoniVie Ltd. 2018-10-31
NCT02378649 PDEI Following Mitral Valve Surgery in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02378649 Completed Sheba Medical Center 2018-06-30
NCT02305550 A Proof of Concept Study of Electrical Discharge Produced Nitric Oxide for Inhalation https://ClinicalTrials.gov/show/NCT02305550 Completed Massachusetts General Hospital 2016-01-31
NCT02290613 Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH) https://ClinicalTrials.gov/show/NCT02290613 Completed Heidelberg University 2017-11-27
NCT02288442 Whole Muscle Exercise Training (WHOLEi+12) in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02288442 Completed Universidad Europea de Madrid 2016-06-30
NCT02261883 Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn https://ClinicalTrials.gov/show/NCT02261883 Recruiting United Therapeutics 2022-12-31
NCT02223481 Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02223481 Completed Boehringer Ingelheim 1999-09-30
NCT02220335 Pulmonary Arterial Denervation in Patients With Pulmonary Hypertension Associated With the Left Heart Failure https://ClinicalTrials.gov/show/NCT02220335 Completed Nanjing First Hospital, Nanjing Medical University 2018-06-16
NCT02216279 Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02216279 Completed Montreal Heart Institute 2015-09-30
NCT02191137 Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION) https://ClinicalTrials.gov/show/NCT02191137 Completed Bayer 2016-07-16
NCT02150616 Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep https://ClinicalTrials.gov/show/NCT02150616 Active, not recruiting University of Zurich 2020-12-31
NCT02143687 Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance https://ClinicalTrials.gov/show/NCT02143687 Active, not recruiting University of Zurich 2020-12-31
NCT02133352 Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction https://ClinicalTrials.gov/show/NCT02133352 Completed Boston University 2013-05-31
NCT02129309 Haemodynamic Effects of Apelin Agonists and Antagonists in Man in COPD With Raised Pulmonary Artery Pressures https://ClinicalTrials.gov/show/NCT02129309 Completed Cambridge University Hospitals NHS Foundation Trust 2014-12-31
NCT02111980 RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators https://ClinicalTrials.gov/show/NCT02111980 Completed University of California, San Diego 2015-03-31
NCT02094001 Pilot Study to Evaluate Right Ventricular Function With Riociguat in CTEPH https://ClinicalTrials.gov/show/NCT02094001 Completed Ottawa Heart Institute Research Corporation 2016-06-30
NCT02026531 Novel MRI Techniques in the Evaluation of Pulmonary Vascular Disease https://ClinicalTrials.gov/show/NCT02026531 Completed Sheffield Teaching Hospitals NHS Foundation Trust 2015-09-30
NCT02070991 Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction https://ClinicalTrials.gov/show/NCT02070991 Completed Actelion 2015-11-01
NCT02060721 Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02060721 Active, not recruiting Actelion 2020-12-31
NCT01313832 The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01313832 Completed Seoul National University Hospital 2011-04-30
NCT01310751 Study of Inhaled Iloprost in Pediatric Pulmonary Hypertension (PH) After Surgery https://ClinicalTrials.gov/show/NCT01310751 Completed Shanghai Jiao Tong University School of Medicine 2013-12-31
NCT01310153 Effect of Supine or Prone Position After Caesarean Birth https://ClinicalTrials.gov/show/NCT01310153 Completed Montefiore Medical Center 2009-02-28
NCT01306292 Safety of SonoVue on Pulmonary Hemodynamics https://ClinicalTrials.gov/show/NCT01306292 Completed Bracco Diagnostics, Inc 2011-11-30
NCT01305252 A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil). https://ClinicalTrials.gov/show/NCT01305252 Completed Stanford University 2014-09-30
NCT01287026 Real-time MRI Right Heart Catheterization Using Passive Catheters https://ClinicalTrials.gov/show/NCT01287026 Completed National Institutes of Health Clinical Center (CC) 2019-03-21
NCT01274481 Iloprost Effects on Gas Exchange and Pulmonary Mechanics https://ClinicalTrials.gov/show/NCT01274481 Completed University of Oklahoma 2012-07-31
NCT02053246 Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure https://ClinicalTrials.gov/show/NCT02053246 Active, not recruiting University of Florida 2021-03-31
NCT02036970 Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT https://ClinicalTrials.gov/show/NCT02036970 Completed Reata Pharmaceuticals, Inc. 2018-01-19
NCT02007629 Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor https://ClinicalTrials.gov/show/NCT02007629 Completed Bayer 2016-12-29
NCT01959828 Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery https://ClinicalTrials.gov/show/NCT01959828 Completed Mallinckrodt 2014-03-31
NCT01948518 Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease https://ClinicalTrials.gov/show/NCT01948518 Completed The Cleveland Clinic 2012-06-30
NCT01932606 Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction https://ClinicalTrials.gov/show/NCT01932606 Completed Mayo Clinic 2014-10-31
NCT01917136 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01917136 Completed University of Pennsylvania 2018-10-31
NCT01895998 Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease https://ClinicalTrials.gov/show/NCT01895998 Completed Duke University 2014-04-30
NCT01889966 VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01889966 Completed Kerckhoff Heart Center 2015-01-31
NCT01884012 Effect of Long-term Oxygen Therapy on Exercise Capacity and Quality of Life in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01884012 Completed University of Zurich 2017-03-31
NCT01862536 Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease https://ClinicalTrials.gov/show/NCT01862536 Active, not recruiting VA Office of Research and Development 2019-08-31
NCT01839110 Targeting the Right Ventricle in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01839110 Completed University of Pennsylvania 2018-01-31
NCT01824290 A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH) https://ClinicalTrials.gov/show/NCT01824290 Active, not recruiting Eli Lilly and Company 2019-03-18
NCT01800292 Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH. https://ClinicalTrials.gov/show/NCT01800292 Completed University of Arizona 2013-12-31
NCT01758744 Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1 https://ClinicalTrials.gov/show/NCT01758744 Completed University of Colorado, Denver 2016-07-31
NCT01748474 Effect of Short-term Oxygen During CPET in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01748474 Completed University of Zurich 2016-03-31
NCT01728220 Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD https://ClinicalTrials.gov/show/NCT01728220 Completed Bellerophon 2014-06-30
NCT01726049 Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH https://ClinicalTrials.gov/show/NCT01726049 Completed University Medical Center Groningen 2014-09-30
NCT01725776 Inhaled Milrinone in Cardiac Surgery https://ClinicalTrials.gov/show/NCT01725776 Completed Montreal Heart Institute 2012-02-29
NCT01725763 Non-contrast Enhanced Cardiac Magnetic Resonance Imaging in the Diagnosis and Classification of Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01725763 Enrolling by invitation Medical University of Graz 2022-12-31
NCT01720524 A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn https://ClinicalTrials.gov/show/NCT01720524 Active, not recruiting Pfizer 2018-10-17
NCT01682356 Dietary Nitrates for Heart Failure (HF) https://ClinicalTrials.gov/show/NCT01682356 Enrolling by invitation Washington University School of Medicine 2019-12-31
NCT01670136 Pharmacokinetics of Sildenafil in Premature Infants https://ClinicalTrials.gov/show/NCT01670136 Completed University of North Carolina, Chapel Hill 2016-07-31
NCT03349775 Cardiometabolic Disease and Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03349775 Recruiting Massachusetts General Hospital 2022-09-01
NCT01642407 Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT01642407 Completed Pfizer 2016-05-20
NCT01621971 Effect of Brief Nebulization of Milrinone on Pulmonary Arterial Pressure Before Cardiopulmonary Bypass on Mitral Valve Surgery Patients https://ClinicalTrials.gov/show/NCT01621971 Completed Konkuk University Medical Center 2004-01-31
NCT01615484 Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability https://ClinicalTrials.gov/show/NCT01615484 Completed University of North Carolina, Chapel Hill 2016-03-31
NCT01607515 Non Invasive Measurement of Cardiac Index by Impedance Cardiography https://ClinicalTrials.gov/show/NCT01607515 Completed Medical University of Graz 2015-06-30
NCT01607489 Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography https://ClinicalTrials.gov/show/NCT01607489 Completed Medical University of Graz 2017-03-31
NCT01598441 Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD) https://ClinicalTrials.gov/show/NCT01598441 Completed Shanghai Jiao Tong University School of Medicine 2016-11-30
NCT01586156 PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol) https://ClinicalTrials.gov/show/NCT01586156 Completed The Cleveland Clinic 2016-07-31
NCT01566565 The Safety Evaluation of Drug Combinations Against High Altitude Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01566565 Completed Norwegian Armed Forces Medical Service 2012-05-31
NCT01539889 Phase-I Study of Radiolabeled DFH-12 (PulmoBind) for Molecular Imaging of the Pulmonary Circulation https://ClinicalTrials.gov/show/NCT01539889 Completed Montreal Heart Institute 2012-06-30
NCT01530464 The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers https://ClinicalTrials.gov/show/NCT01530464 Completed Duke University 2012-04-30
NCT01529502 Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This Setting https://ClinicalTrials.gov/show/NCT01529502 Completed Massachusetts General Hospital 2013-12-31
NCT02024386 Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude https://ClinicalTrials.gov/show/NCT02024386 Completed Duke University 2015-12-31
NCT01481350 Sildenafil for Post-capillary Pulmonary Hypertension in Patients Undergoing Cardiac Surgery https://ClinicalTrials.gov/show/NCT01481350 Completed University of Turin, Italy 2013-06-30
NCT01469169 Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Study https://ClinicalTrials.gov/show/NCT01469169 Completed Bayer 2014-12-26
NCT01463514 Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01463514 Completed University of Zurich 2013-06-30
NCT01462565 Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH) https://ClinicalTrials.gov/show/NCT01462565 Completed GlaxoSmithKline 2012-05-16
NCT01457781 Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH) https://ClinicalTrials.gov/show/NCT01457781 Completed Bellerophon 2014-10-31
NCT01446848 Oral Iron Supplementation in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01446848 Completed The Cleveland Clinic 2014-08-31
NCT01431313 Inhaled Nitrite in Subjects With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01431313 Completed University of Pittsburgh 2017-10-31
NCT01427192 Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01427192 Completed University of Zurich 2012-12-31
NCT01416636 Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH) https://ClinicalTrials.gov/show/NCT01416636 Active, not recruiting SciPharm SàRL 2016-11-30
NCT01409122 Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects https://ClinicalTrials.gov/show/NCT01409122 Completed Aires Pharmaceuticals, Inc. 2012-01-31
NCT01398345 Exercise and Respiratory Training as Supportive Treatments for Patients With Chronic Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01398345 Completed Heidelberg University 2006-12-31
NCT01394367 Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life and Right Ventricular Function in Severe Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01394367 Completed Heidelberg University 2015-05-31
NCT01393795 Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients https://ClinicalTrials.gov/show/NCT01393795 Completed Imperial College London 2012-07-31
NCT01364181 The Impact of Udenafil on Exercise Capacity in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients https://ClinicalTrials.gov/show/NCT01364181 Completed Seoul National University Hospital 2011-03-31
NCT01352065 Characterization and Detection of Prolonged Endothelin Receptors Antagonists Administration https://ClinicalTrials.gov/show/NCT01352065 Completed Center for Health, Exercise and Sport Sciences, Serbia 2012-12-31
NCT01342952 Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529 https://ClinicalTrials.gov/show/NCT01342952 Active, not recruiting GlaxoSmithKline 2022-06-13
NCT01330108 Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01330108 Completed University of Alabama at Birmingham 2012-06-30
NCT01324999 Tadalafil for Sarcoidosis Associated Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01324999 Completed University of North Carolina, Chapel Hill 2013-07-31
NCT01320878 Study of Inhaled Iloprost for the Treatment of Pulmonary Hypertension After Repair of Congenital Heart Disease https://ClinicalTrials.gov/show/NCT01320878 Completed Shanghai Jiao Tong University School of Medicine 2009-07-31
NCT04391478 Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT04391478 Completed Ain Shams University 2015-04-30
NCT04373902 Physiological-based Cord Clamping in Congenital Diaphragmatic Hernia https://ClinicalTrials.gov/show/NCT04373902 Recruiting Erasmus Medical Center 2023-06-01
NCT04370873 MK-5475 in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006) https://ClinicalTrials.gov/show/NCT04370873 Recruiting Merck Sharp & Dohme Corp. 2021-05-07
NCT04328636 Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn https://ClinicalTrials.gov/show/NCT04328636 Completed Sohag University 2019-10-31
NCT04326777 Clinical Study of Balloon Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT04326777 Recruiting Beijing Chao Yang Hospital 2023-04-30
NCT04262037 A Comparative Study of Three Modes of Ventilation During CPB in Pediatrics With Pulmonary Hypertension Undergoing Congenital Heart Surgeries https://ClinicalTrials.gov/show/NCT04262037 Recruiting Cairo University 2020-07-31
NCT04224025 Training Single Arm https://ClinicalTrials.gov/show/NCT04224025 Recruiting Heidelberg University 2025-12-31
NCT04224012 Effect of Exercise and Respiratory Therapy on Right Ventricular Function in Severe Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT04224012 Recruiting Heidelberg University 2021-08-31
NCT04197388 Inspiratory Muscle Training in Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT04197388 Recruiting Golden Jubilee National Hospital 2021-04-01
NCT04152187 Effects of Inspiratory Muscle Training in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT04152187 Recruiting Dokuz Eylul University 2021-05-31
NCT04095286 Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants https://ClinicalTrials.gov/show/NCT04095286 Completed GlaxoSmithKline 2019-12-17
NCT04088279 Novel Quantitative Magnetic Resonance Imaging (MRI) Measures in the Assessment and Follow-up of Patients With Pulmonary Hypertension (PH) https://ClinicalTrials.gov/show/NCT04088279 Recruiting Royal Brompton & Harefield NHS Foundation Trust 2020-12-31
NCT04081012 N-acetyl Cysteine in Post-reperfusion Pulmonary Injury in Chronic Thromboembolic Pulmonary Hypertension. https://ClinicalTrials.gov/show/NCT04081012 Recruiting Instituto Nacional de Cardiologia Ignacio Chavez 2023-05-21
NCT04076241 Effects of Complementary Therapy on Cardiopulmonary Parameters in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT04076241 Enrolling by invitation Istanbul University-Cerrahpasa 2020-09-30
NCT04055415 Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT04055415 Recruiting Liaocheng People’s Hospital 2020-08-01
NCT04053361 Catheter Ablation of Atrial Fibrillation in Patients With Pulmonary Hypertension Hypertension: a Randomised Study https://ClinicalTrials.gov/show/NCT04053361 Recruiting General University Hospital, Prague 2020-12-31
NCT04031508 Effect of a Parenteral Emulsion With Omega3 on PPHN https://ClinicalTrials.gov/show/NCT04031508 Active, not recruiting Coordinación de Investigación en Salud, Mexico 2022-07-31
NCT04008550 Prognostic Impact of the Evolution of PAH 3 Months After TAVI (HTP-TAVI) https://ClinicalTrials.gov/show/NCT04008550 Recruiting University Hospital, Rouen 2021-03-05
NCT03992755 Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil https://ClinicalTrials.gov/show/NCT03992755 Active, not recruiting Liquidia Technologies, Inc. 2021-12-31
NCT03955016 Rehabilitation for Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03955016 Recruiting KU Leuven 2020-11-01
NCT03928002 4DFlow Magnetic Resonance Imaging in Patients With Pulmonary Hypertension Associated With Congenital Heart Disease https://ClinicalTrials.gov/show/NCT03928002 Recruiting Centre Chirurgical Marie Lannelongue 2020-04-01
NCT03901287 Quantitative Dual Energy Computed Tomography in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03901287 Recruiting University Hospital, Bordeaux 2020-12-15
NCT03854071 Development of Novel Physiological CMR Methods in Health and Disease https://ClinicalTrials.gov/show/NCT03854071 Recruiting Sheffield Teaching Hospitals NHS Foundation Trust 2022-06-04
NCT03835676 Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT03835676 Recruiting Magdi Yacoub Heart Foundation 2022-06-01
NCT03814317 Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03814317 Recruiting University of Florida 2020-09-30
NCT03810482 Pedometers and Walking Tests for Pulmonary Hypertension Patients https://ClinicalTrials.gov/show/NCT03810482 Recruiting University Hospital, Montpellier 2021-06-21
NCT03809650 A Clinical Study to Find Out if Macitentan is Effective and Safe in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH). https://ClinicalTrials.gov/show/NCT03809650 Recruiting Actelion 2022-12-31
NCT03809156 Upfront Combination Pulmonary Arterial Hypertension Therapy https://ClinicalTrials.gov/show/NCT03809156 Recruiting University of Calgary 2020-12-31
NCT03795740 Pulmonary Endarterectomy Guided by CT Scanning for Patients With Chronic Thromboembolic Pulmonary Hypertension—-PEACT https://ClinicalTrials.gov/show/NCT03795740 Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital 2020-05-31
NCT03794583 Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD) https://ClinicalTrials.gov/show/NCT03794583 Enrolling by invitation United Therapeutics 2020-12-31
NCT03780803 Effect of Home Rehabilitation on State of Patients With PAH, HFREF and IHD https://ClinicalTrials.gov/show/NCT03780803 Recruiting Medical University of Bialystok 2020-12-31
NCT03763045 Sildenafil in Hemodialysis Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03763045 Active, not recruiting Ain Shams University 2019-02-16
NCT03762577 Effects of Ground-based Walking Training in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03762577 Completed Istanbul University 2020-03-04
NCT03757481 Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE https://ClinicalTrials.gov/show/NCT03757481 Recruiting University Hospital, Montpellier 2020-10-17
NCT03754660 This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) https://ClinicalTrials.gov/show/NCT03754660 Recruiting Bayer 2021-06-22
NCT03729544 Computerized Decision Support to Increase Detection of Chronic Thromboembolic Pulmonary Hypertension in Patients With Prior Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03729544 Recruiting Brigham and Women’s Hospital 2021-01-30
NCT03727451 A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis https://ClinicalTrials.gov/show/NCT03727451 Recruiting Bellerophon 2020-06-30
NCT03719027 Prevalence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism : (Preva-CTEPH) https://ClinicalTrials.gov/show/NCT03719027 Recruiting Assistance Publique - Hôpitaux de Paris 2020-12-31
NCT03689244 A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or International Treatment https://ClinicalTrials.gov/show/NCT03689244 Recruiting Actelion 2021-03-26
NCT03673774 Impedancemetry in Patients Monitored for Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03673774 Recruiting University Hospital, Toulouse 2019-08-31
NCT03649932 Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing https://ClinicalTrials.gov/show/NCT03649932 Recruiting The University of Texas Medical Branch, Galveston 2019-09-10
NCT03648385 Effects of DHEA in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03648385 Recruiting Rhode Island Hospital 2023-04-30
NCT03637218 Acute Exposure of High Altitude on Cardiac Output https://ClinicalTrials.gov/show/NCT03637218 Completed University of Zurich 2019-01-01
NCT03637192 Acute Exposure of High Altitude on Cognitive Function https://ClinicalTrials.gov/show/NCT03637192 Completed University of Zurich 2019-01-01
NCT03637179 Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo) Under Exercise https://ClinicalTrials.gov/show/NCT03637179 Completed University of Zurich 2019-01-01
NCT03637166 Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo) https://ClinicalTrials.gov/show/NCT03637166 Completed University of Zurich 2019-01-01
NCT03637153 Acute Exposure to High Altitude on Exercise Capacity https://ClinicalTrials.gov/show/NCT03637153 Completed University of Zurich 2019-01-01
NCT03637140 Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function (Echo) Under Exercise https://ClinicalTrials.gov/show/NCT03637140 Completed University of Zurich 2019-04-01
NCT03637127 Acute Exposure of Simulated Hypoxia on Cognitive Function https://ClinicalTrials.gov/show/NCT03637127 Completed University of Zurich 2019-04-01
NCT03637114 Acute Exposure of Simulated Hypoxia on Blood and Tissue Oxygenation (aBGA, NIRS) https://ClinicalTrials.gov/show/NCT03637114 Completed University of Zurich 2019-04-01
NCT03637088 Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function (Echo) https://ClinicalTrials.gov/show/NCT03637088 Completed University of Zurich 2019-04-01
NCT03630211 Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis https://ClinicalTrials.gov/show/NCT03630211 Recruiting University of Pittsburgh 2023-08-01
NCT03624010 Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients https://ClinicalTrials.gov/show/NCT03624010 Active, not recruiting Tenax Therapeutics, Inc. 2022-04-30
NCT03611270 TReatment of Pulmonary Hypertension Group II Study https://ClinicalTrials.gov/show/NCT03611270 Recruiting SoniVie Ltd. 2020-07-31
NCT03600415 Acute Exposure to High Altitude on Blood and Tissue Oxygenation (ABGA, NIRS) https://ClinicalTrials.gov/show/NCT03600415 Completed University of Zurich 2019-01-01
NCT03593096 Acute Exposure to High Altitude on Heart Rate and Ventilation During Exercise https://ClinicalTrials.gov/show/NCT03593096 Completed University of Zurich 2019-01-01
NCT03593083 Acute Excposure of High Altitude on ECG and Non-invasive Blood Pressure. https://ClinicalTrials.gov/show/NCT03593083 Completed University of Zurich 2019-01-01
NCT03593005 Acute Exposure to High Altitude on Symptoms https://ClinicalTrials.gov/show/NCT03593005 Completed University of Zurich 2019-01-01
NCT03592979 Acute Exposure of Simulated Hypoxia on Heart Rate and Ventilation During Exercise https://ClinicalTrials.gov/show/NCT03592979 Completed University of Zurich 2019-04-01
NCT03592927 Acute Exposure to Simulated Hypoxia on Exercise Capacity https://ClinicalTrials.gov/show/NCT03592927 Completed University of Zurich 2019-04-01
NCT03581877 Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE https://ClinicalTrials.gov/show/NCT03581877 Recruiting Northwell Health 2021-12-31
NCT03581851 Acute Exposure of Simulated Hypoxia on ECG and Non-invasive Blood Pressure https://ClinicalTrials.gov/show/NCT03581851 Completed University of Zurich 2019-04-01
NCT03576885 Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia https://ClinicalTrials.gov/show/NCT03576885 Recruiting AdventHealth 2021-08-31
NCT03574675 Acute Exposure of Simulated Hypoxia on Cardiac Output https://ClinicalTrials.gov/show/NCT03574675 Completed University of Zurich 2019-04-01
NCT03554291 Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03554291 Recruiting University of Washington 2022-07-31
NCT03550729 Effects of Physical Training on Vascular Function as a Therapeutic Target in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03550729 Recruiting Hospital Clinic of Barcelona 2019-08-31
NCT03542812 L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia https://ClinicalTrials.gov/show/NCT03542812 Recruiting University of Utah 2021-06-30
NCT03541603 Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF https://ClinicalTrials.gov/show/NCT03541603 Completed Tenax Therapeutics, Inc. 2020-04-07
NCT03528902 Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT03528902 Recruiting Vanderbilt University Medical Center 2022-06-30
NCT03523910 Right Ventricular Pulmonary Vascular Interaction in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03523910 Completed University of Wisconsin, Madison 2017-02-13
NCT03496623 A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With PH Due to COPD https://ClinicalTrials.gov/show/NCT03496623 Recruiting United Therapeutics 2020-09-30
NCT03438123 Data Collection Study for the Spectrum Dynamics Multi-purpose CZT SPECT Camera https://ClinicalTrials.gov/show/NCT03438123 Completed Spectrum Dynamics 2019-10-15
NCT03431649 Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in Children https://ClinicalTrials.gov/show/NCT03431649 Completed Dr. Soetomo General Hospital 2017-07-30
NCT01260454 The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain https://ClinicalTrials.gov/show/NCT01260454 Completed University of Rochester 2011-12-31
NCT01224210 Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial https://ClinicalTrials.gov/show/NCT01224210 Active, not recruiting Tufts Medical Center 2016-10-31
NCT01212523 Effects of Propofol and Isoflurane on Pulmonary Vascular Resistance https://ClinicalTrials.gov/show/NCT01212523 Completed University Hospitals Bristol NHS Foundation Trust 2011-12-31
NCT01197469 Do Phosphodiesterase 5A Inhibitors Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension? https://ClinicalTrials.gov/show/NCT01197469 Completed University of Dundee 2012-09-30
NCT01185730 Prospective Longitudinal Study of Patients With Idiopathic Pulmonary Arterial Hypertension, Family or Taking Anorectics https://ClinicalTrials.gov/show/NCT01185730 Completed Assistance Publique - Hôpitaux de Paris 2016-01-31
NCT01179334 Evaluation of the Pharmacodynamic Effect of the Combination of Sildenafil and Riociguat on Blood Pressure and Other Safety Parameters. https://ClinicalTrials.gov/show/NCT01179334 Completed Bayer 2012-06-30
NCT01178073 A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) https://ClinicalTrials.gov/show/NCT01178073 Completed GlaxoSmithKline 2014-07-31
NCT01156636 Phosphodiesterase-5 (PDE5) Inhibition and Pulmonary Hypertension in Diastolic Heart Failure https://ClinicalTrials.gov/show/NCT01156636 Completed University of Milan 2009-09-30
NCT01121458 Clevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial Bed https://ClinicalTrials.gov/show/NCT01121458 Completed North Texas Veterans Healthcare System 2013-04-30
NCT01104870 A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01104870 Completed United Therapeutics 2013-01-31
NCT01100008 Cardiac Magnetic Resonance Imaging and Pulmonary Perfusion https://ClinicalTrials.gov/show/NCT01100008 Completed University Hospital, Toulouse 2013-09-30
NCT01083524 Dichloroacetate (DCA) for the Treatment of Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT01083524 Completed University of Alberta 2013-09-30
NCT01065454 A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction https://ClinicalTrials.gov/show/NCT01065454 Active, not recruiting Bayer 2012-06-06
NCT01055405 Study of Sildenafil Effects in Combination With Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Associated Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01055405 Completed Hospital Clinic of Barcelona 2011-03-31
NCT01051960 Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan https://ClinicalTrials.gov/show/NCT01051960 Completed University of California, Los Angeles 2010-06-30
NCT01048905 Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01048905 Completed UCSF Benioff Children’s Hospital Oakland 2014-03-31
NCT01042158 A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis https://ClinicalTrials.gov/show/NCT01042158 Completed Johns Hopkins University 2014-11-30
NCT01038284 Multidisciplinary Collaboration Care in Pulmonary Arterial Hypertension (PAH) https://ClinicalTrials.gov/show/NCT01038284 Completed University Hospital, Grenoble 2014-02-28
NCT00984932 Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00984932 Completed University of Alexandria 2009-07-31
NCT00963027 Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil https://ClinicalTrials.gov/show/NCT00963027 Completed United Therapeutics 2009-10-31
NCT00963001 Effect of Food on the Pharmacokinetics of Oral Treprostinil https://ClinicalTrials.gov/show/NCT00963001 Completed United Therapeutics 2009-11-30
NCT00952302 Study of the Effects of Iron Levels on the Lungs at High Altitude https://ClinicalTrials.gov/show/NCT00952302 Completed University of Oxford 2008-11-30
NCT00910429 BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00910429 Completed Bayer 2019-08-19
NCT00909337 Early Therapy of Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00909337 Completed Medical University of Graz 2010-06-30
NCT00887978 Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00887978 Completed United Therapeutics 2011-07-31
NCT00878878 Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR). https://ClinicalTrials.gov/show/NCT00878878 Completed GE Healthcare 2010-07-31
NCT00872170 Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00872170 Completed HealthCore-NERI 2010-06-30
NCT00863681 BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00863681 Completed Bayer 2019-08-19
NCT00862043 Sildenafil for Secondary Pulmonary Hypertension Due to Valvular Disease https://ClinicalTrials.gov/show/NCT00862043 Completed Hospital General Universitario Gregorio Marañon 2016-07-31
NCT00855465 A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. https://ClinicalTrials.gov/show/NCT00855465 Completed Bayer 2012-06-30
NCT02021292 Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02021292 Completed Actelion 2016-09-28
NCT00851929 Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00851929 Completed Medical University of South Carolina 2011-04-30
NCT03388476 Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03388476 Enrolling by invitation University of Giessen 2021-01-01
NCT03229499 Pulmonary Hypertension and Anastrozole Trial https://ClinicalTrials.gov/show/NCT03229499 Active, not recruiting University of Pennsylvania 2021-09-30
NCT03199131 The Right Ventricle in Chronic Pressure Overload: Identifying Novel Molecular Targets for Functional Imaging https://ClinicalTrials.gov/show/NCT03199131 Completed Centre Chirurgical Marie Lannelongue 2017-11-20
NCT00810693 A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) https://ClinicalTrials.gov/show/NCT00810693 Completed Bayer 2012-05-31
NCT00808912 Does Sildenafil Increase Exercise Performance in Air Pollution? https://ClinicalTrials.gov/show/NCT00808912 Completed Marywood University 2010-02-28
NCT02951429 Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02951429 Active, not recruiting Hoffmann-La Roche 2019-09-26
NCT02760121 AZ, MZ, and the Pulmonary System Response to Hypoxia https://ClinicalTrials.gov/show/NCT02760121 Completed University of British Columbia 2016-08-31
NCT03683186 A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension https://ClinicalTrials.gov/show/NCT03683186 Enrolling by invitation United Therapeutics 2024-09-30
NCT02345616 Role of the Nitric Oxide (NO) in Pre-oxygenation Before Anesthetic Induction in Patients With a Pulmonary Hypertension in Cardiac Surgery. Pilot Study of Feasibility https://ClinicalTrials.gov/show/NCT02345616 Recruiting University Hospital, Clermont-Ferrand 2019-12-31
NCT02267655 3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF https://ClinicalTrials.gov/show/NCT02267655 Completed Bellerophon 2017-06-30
NCT01829672 Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography https://ClinicalTrials.gov/show/NCT01829672 Completed Medical University of Graz 2017-03-31
NCT03726398 CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH https://ClinicalTrials.gov/show/NCT03726398 Recruiting University of Arizona 2020-01-31
NCT00777920 Study of Ambrisentan in Subjects With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00777920 Completed Gilead Sciences 2019-09-11
NCT00759408 The Role of Endothelin in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00759408 Completed Brigham and Women’s Hospital 2010-10-31
NCT00747045 Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) Patients https://ClinicalTrials.gov/show/NCT00747045 Completed University of California, San Diego 2011-03-31
NCT00739375 The Effect of Blood Flow in the Maturing Arteriovenous Access for Hemodialysis on the Development of Pulmonary Hypertension. https://ClinicalTrials.gov/show/NCT00739375 Completed Shaare Zedek Medical Center 2012-04-30
NCT00718952 The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00718952 Completed Tongji University 2009-12-31
NCT00694850 Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH) https://ClinicalTrials.gov/show/NCT00694850 Active, not recruiting Bayer 2021-10-01
NCT00680654 Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TID https://ClinicalTrials.gov/show/NCT00680654 Completed Bayer 2009-08-31
NCT00678821 Aerobic Exercise in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00678821 Completed National Institutes of Health Clinical Center (CC) 2015-09-23
NCT00800592 Sildenafil IV Bolus Study https://ClinicalTrials.gov/show/NCT00800592 Completed Pfizer 2008-12-31
NCT00657722 Identification of Criteria of the Success of the Endarterectomy in Chronic Pulmonary Post Embolic Hypertension https://ClinicalTrials.gov/show/NCT00657722 Completed Assistance Publique - Hôpitaux de Paris 2011-07-31
NCT00644605 A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00644605 Completed Pfizer NA
NCT00640315 Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension. https://ClinicalTrials.gov/show/NCT00640315 Completed Bayer 2009-09-30
NCT00615823 Atorvastatin in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00615823 Completed Chinese Academy of Medical Sciences, Fuwai Hospital 2010-03-31
NCT00595049 Pulmonary Artery Remodelling With Bosentan https://ClinicalTrials.gov/show/NCT00595049 Completed Actelion 2008-12-31
NCT00581607 Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00581607 Completed University of Cincinnati 2012-10-31
NCT00561223 Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT00561223 Completed University of Oklahoma 2008-04-30
NCT00559442 Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Hypoxic Pulmonary Vasoconstriction https://ClinicalTrials.gov/show/NCT00559442 Completed Heidelberg University 2010-12-31
NCT00554619 A Study to Evaluate GSK1325760A - a Long-Term Extension Study https://ClinicalTrials.gov/show/NCT00554619 Completed GlaxoSmithKline 2011-01-31
NCT00549302 Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs https://ClinicalTrials.gov/show/NCT00549302 Completed Eli Lilly and Company 2012-02-29
NCT00540436 Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00540436 Completed GlaxoSmithKline 2009-01-31
NCT00519870 Losartan Therapy in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00519870 Completed Baskent University NA
NCT00517933 Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT00517933 Completed Duke University 2009-05-31
NCT00491803 Sildenafil Effects on Pulmonary Haemodynamics and Gas Exchange in Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT00491803 Completed Hospital Clinic of Barcelona 2008-11-30
NCT00491309 Exercise and Respiratory Therapy in Patients With Rheumatoid Arthritis / Collagenosis and Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00491309 Recruiting Heidelberg University 2022-12-31
NCT00477724 Latent Pulmonary Hypertension (PH) in Chronic Thromboembolic Pulmonary Hypertension (CTEPH )After Endarterectomy and Influence of Exercise and Respiratory Therapy https://ClinicalTrials.gov/show/NCT00477724 Recruiting Heidelberg University 2022-12-31
NCT00469027 Pulmonary Hypertension: Assessment of Cell Therapy https://ClinicalTrials.gov/show/NCT00469027 Completed Northern Therapeutics 2012-07-31
NCT00454558 An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00454558 Completed Bayer 2014-07-31
NCT00454207 Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00454207 Completed Pfizer 2009-02-28
NCT00432978 Effect of Bosentan on Exercise Capacity at High Altitude https://ClinicalTrials.gov/show/NCT00432978 Completed VA Loma Linda Health Care System NA
NCT00424021 Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00424021 Completed Gilead Sciences 2009-12-31
NCT00423592 Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00423592 Completed Gilead Sciences 2006-01-31
NCT00414687 Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00414687 Completed Bayer NA
NCT00403650 Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00403650 Completed University of Cincinnati 2008-07-31
NCT00820352 Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00820352 Completed University Teaching Hospital Hall in Tirol 2014-06-30
NCT00380068 Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00380068 Completed Gilead Sciences 2008-07-31
NCT00927654 Iloprost in High Risk Cardiac Surgical Patients https://ClinicalTrials.gov/show/NCT00927654 Completed Ludwig-Maximilians - University of Munich 2012-03-31
NCT00373360 Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin https://ClinicalTrials.gov/show/NCT00373360 Completed United Therapeutics 2008-01-31
NCT00359736 Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT00359736 Completed VA Office of Research and Development 2008-10-31
NCT00352482 Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00352482 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00352430 Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00352430 Completed National Institutes of Health Clinical Center (CC) 2010-03-10
NCT00345774 Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT00345774 Completed Epix Pharmaceuticals, Inc. NA
NCT00335244 Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery https://ClinicalTrials.gov/show/NCT00335244 Completed Asklepion Pharmaceuticals, LLC 2009-12-31
NCT00334490 Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery? https://ClinicalTrials.gov/show/NCT00334490 Completed St. Michael’s Hospital, Toronto 2009-04-30
NCT00325442 FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH) https://ClinicalTrials.gov/show/NCT00325442 Completed United Therapeutics 2008-09-30
NCT00325403 FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) https://ClinicalTrials.gov/show/NCT00325403 Completed United Therapeutics 2011-04-30
NCT00319111 Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) https://ClinicalTrials.gov/show/NCT00319111 Completed Actelion 2009-02-28
NCT00314548 Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00314548 Completed Aga Khan University 2009-07-31
NCT00313222 Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00313222 Completed Actelion 2007-02-28
NCT00274430 Prevention of High Altitude Pulmonary Edema https://ClinicalTrials.gov/show/NCT00274430 Completed University of Zurich NA
NCT00270478 Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia https://ClinicalTrials.gov/show/NCT00270478 Completed National Institutes of Health Clinical Center (CC) 2009-08-31
NCT00240656 Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00240656 Completed Hebei Medical University NA
NCT00235521 Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery https://ClinicalTrials.gov/show/NCT00235521 Completed Heidelberg University 2008-10-31
NCT00205426 Natrecor for Pulmonary Hypertension in Lung Transplants https://ClinicalTrials.gov/show/NCT00205426 Completed University of Wisconsin, Madison 2006-05-31
NCT00190333 Serotonin Transporter Inhibitor Escitalopram in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00190333 Completed Assistance Publique - Hôpitaux de Paris 2008-12-31
NCT00185315 Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00185315 Completed Bayer NA
NCT00180713 Simvastatin as a Treatment for Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00180713 Completed Imperial College London 2008-10-31
NCT00159887 Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00159887 Completed Pfizer NA
NCT00159861 The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH https://ClinicalTrials.gov/show/NCT00159861 Completed Pfizer NA
NCT00147199 Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH) https://ClinicalTrials.gov/show/NCT00147199 Completed United Therapeutics 2007-10-31
NCT00139217 NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn https://ClinicalTrials.gov/show/NCT00139217 Completed Emory University 2007-09-30
NCT00125918 PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00125918 Completed Eli Lilly and Company 2007-08-31
NCT00109681 Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT00109681 Completed Actelion 2006-10-31
NCT00105209 A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00105209 Completed Kawut, Steven, MD NA
NCT00091715 Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II https://ClinicalTrials.gov/show/NCT00091715 Completed Actelion 2006-11-30
NCT00091598 ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH) https://ClinicalTrials.gov/show/NCT00091598 Completed Gilead Sciences 2006-02-28
NCT00819377 Milrinone Inhaled in Cardiac Surgery https://ClinicalTrials.gov/show/NCT00819377 Completed Montreal Heart Institute 2012-01-31
NCT00086463 Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH) https://ClinicalTrials.gov/show/NCT00086463 Completed Actelion 2006-01-31
NCT00082186 The Effect of Tracleer® on Male Fertility https://ClinicalTrials.gov/show/NCT00082186 Completed Actelion 2007-02-28
NCT00080457 Safety and Efficacy Study of Sitaxentan Sodium (Thelinâ„¢) in Patients With Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00080457 Completed Encysive Pharmaceuticals NA
NCT00058929 A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00058929 Completed United Therapeutics 2005-08-31
NCT00046319 Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT00046319 Completed Gilead Sciences NA
NCT00023296 Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00023296 Completed National Institutes of Health Clinical Center (CC) 2006-11-02
NCT00004805 Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death https://ClinicalTrials.gov/show/NCT00004805 Completed Office of Rare Diseases (ORD) NA
NCT00004754 Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00004754 Completed Office of Rare Diseases (ORD) NA
NCT00004497 Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00004497 Completed FDA Office of Orphan Products Development NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03396120 The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT03396120 Completed Assiut University 2017-12-01
NCT03304548 Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) Subjects https://ClinicalTrials.gov/show/NCT03304548 Completed GlaxoSmithKline 2018-04-10
NCT03293407 Evaluation of Inhaled Iloprost Effects Using the Breelib Nebulizer, on Clinical Outcomes and Physical Activity of Patients With Advanced Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT03293407 Completed Bayer 2019-10-09
NCT03269630 New Orleans Pulmonary Hypertension Biobank https://ClinicalTrials.gov/show/NCT03269630 Recruiting Louisiana State University Health Sciences Center in New Orleans 2027-10-31
NCT03198910 Retrospective Data Analysis of Data From the Zurich PH Registry https://ClinicalTrials.gov/show/NCT03198910 Completed University of Zurich 2017-09-01
NCT03195959 Effect of Normobaric Hypoxia and Hyperoxia in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03195959 Recruiting University of Zurich 2020-12-31
NCT03195543 Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03195543 Recruiting National and Kapodistrian University of Athens 2020-12-31
NCT03155373 The Right Ventricular Pulmonary Circulation Continuum in Mitral Valve Disease Study https://ClinicalTrials.gov/show/NCT03155373 Completed Imperial College London 2019-03-01
NCT03134898 Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03134898 Recruiting Sociedad Española de Neumología y Cirugía Torácica 2019-06-30
NCT03133169 Erythrocyte Glutamine Level Relation to Pulmonary Hypertension Risk in Beta Thalassemia Major Children https://ClinicalTrials.gov/show/NCT03133169 Completed Assiut University 2019-08-25
NCT03061669 Respiratory Monitoring During Right Heart https://ClinicalTrials.gov/show/NCT03061669 Recruiting Rambam Health Care Campus 2020-02-29
NCT03051763 The Effects of Commercial Air Travel on Patients Suffering From Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03051763 Recruiting University of Giessen 2019-12-19
NCT03045614 Kidney Disease and Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03045614 Completed University of Giessen 2018-08-27
NCT03030807 Pulmonary Hypertension in Hypersensitivity Pneumonitis https://ClinicalTrials.gov/show/NCT03030807 Enrolling by invitation Medical University of Graz 2020-10-31
NCT02940327 Markers of Inflammation and Lung Recovery in ECMO Patients for PPHN https://ClinicalTrials.gov/show/NCT02940327 Completed University of Leicester 2017-07-10
NCT02909608 Actigraphy in Pediatric Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02909608 Recruiting University of Colorado, Denver 2020-03-31
NCT02873039 Correlation Between Estimated Right Atrial Pressure and BNP in Pulmonary HTN (CRAB-PH) https://ClinicalTrials.gov/show/NCT02873039 Recruiting Louisiana State University Health Sciences Center in New Orleans 2018-05-31
NCT02865577 Right Heart Dysfunction and Pulmonary Hypertension Evaluation in Airway Disease Using Cardiac Magnetic Resonance https://ClinicalTrials.gov/show/NCT02865577 Completed University of Leicester 2017-11-29
NCT02858791 MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT02858791 Completed Northwell Health 2017-12-21
NCT02826252 Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20) https://ClinicalTrials.gov/show/NCT02826252 Completed Bayer 2016-11-15
NCT02825160 Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH) https://ClinicalTrials.gov/show/NCT02825160 Recruiting Bayer 2022-03-31
NCT02800941 Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02800941 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2020-12-31
NCT02799771 HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSION https://ClinicalTrials.gov/show/NCT02799771 Active, not recruiting Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires 2018-02-28
NCT02789449 Estimation of Pulmonary Capillary Blood Volume in Pre- and Postcapillary Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02789449 Completed Medical University of Graz 2018-12-31
NCT02752269 Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren Syndrome https://ClinicalTrials.gov/show/NCT02752269 Completed Medical University of Graz 2019-06-30
NCT02743091 Idiopathic Pre-capillary Pulmonary Hypertension in ESKD Patients https://ClinicalTrials.gov/show/NCT02743091 Completed Toujinkai Hospital 2015-12-31
NCT02647060 The Exercise Capacity and Quality of Life in the Patients With IPAH and Secondary PH https://ClinicalTrials.gov/show/NCT02647060 Completed National Taiwan University Hospital 2016-04-30
NCT02637050 A Study Investigating Routine Practice of Chronic Thromboembolic Pulmonary Hypertension Management in EMEA Countries https://ClinicalTrials.gov/show/NCT02637050 Active, not recruiting Bayer 2020-06-30
NCT02594917 Genetic and Environmental Determinants That Control Metabolism in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02594917 Recruiting University of Pittsburgh 2021-09-30
NCT02576002 Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension) https://ClinicalTrials.gov/show/NCT02576002 Completed Bayer 2016-01-31
NCT00011648 Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia https://ClinicalTrials.gov/show/NCT00011648 Completed National Institutes of Health Clinical Center (CC) NA
NCT02565030 Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term Outcome https://ClinicalTrials.gov/show/NCT02565030 Active, not recruiting Sheffield Teaching Hospitals NHS Foundation Trust 2021-10-31
NCT01730092 Natural History Study of Biomarkers in Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT01730092 Recruiting National Institutes of Health Clinical Center (CC) 2022-08-31
NCT02545465 A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice https://ClinicalTrials.gov/show/NCT02545465 Completed Bayer 2016-05-31
NCT02536534 Electronic Activity Level Monitoring Pilot in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02536534 Completed Bayer 2016-11-25
NCT02485977 Cardiac MRI in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02485977 Completed University of California, San Francisco 2017-06-30
NCT02428985 Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH) https://ClinicalTrials.gov/show/NCT02428985 Recruiting Bayer 2022-09-30
NCT02377934 Evaluation of Radiation Induced Pulmonary Hypertension Using MRI in Stage III NSCLC Patients Treated With Chemoradiotherapy. A Pilot Study https://ClinicalTrials.gov/show/NCT02377934 Completed University Medical Center Groningen 2015-08-31
NCT02331225 Endothelial Microparticles in Systemic Sclerosis Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02331225 Completed Louisiana State University Health Sciences Center in New Orleans 2016-07-31
NCT02299960 Measurement of Endothelial Function and Cardiac Output: New Methods https://ClinicalTrials.gov/show/NCT02299960 Completed Charite University, Berlin, Germany 2015-09-30
NCT02275793 The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure https://ClinicalTrials.gov/show/NCT02275793 Completed University of Toledo Health Science Campus 2015-06-30
NCT02268630 Long Term Outcomes of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02268630 Recruiting Ostfold Hospital Trust 2023-10-31
NCT02267200 The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHD https://ClinicalTrials.gov/show/NCT02267200 Completed Shanghai Jiao Tong University School of Medicine 2016-09-30
NCT02223559 Non-invasive Assessment of Pulmonary Artery Pressure https://ClinicalTrials.gov/show/NCT02223559 Completed Medical University of Graz 2017-06-30
NCT02114047 Pulmonary Perfusion Heterogeneity in Patients With CTEPH Using Functional PET Imaging https://ClinicalTrials.gov/show/NCT02114047 Completed Massachusetts General Hospital 2017-01-31
NCT02092818 EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02092818 Completed Bayer 2018-03-31
NCT01281371 Observation Study of the Medication Switch at Patients Treated With Sitaxentan to a Regime Without Sitaxentan https://ClinicalTrials.gov/show/NCT01281371 Completed Heidelberg University 2013-06-30
NCT01971450 Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01971450 Completed Bayer 2017-06-28
NCT01961232 Trans-pulmonary Biomarkers in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01961232 Active, not recruiting Vanderbilt University Medical Center 2015-01-31
NCT01894035 Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation https://ClinicalTrials.gov/show/NCT01894035 Completed Bayer 2016-07-20
NCT01801982 A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN) https://ClinicalTrials.gov/show/NCT01801982 Completed Pfizer 2013-12-31
NCT01794130 The Incidence of Subclinical High-altitude Pulmonary Oedema at High Altitude https://ClinicalTrials.gov/show/NCT01794130 Completed Institute of Mountain Emergency Medicine 2011-07-31
NCT01787162 Screening for Pulmonary Vascular Changes in Patients With Chronic Myeloproliferative Diseases https://ClinicalTrials.gov/show/NCT01787162 Completed Medical University of Graz 2015-06-30
NCT01783093 Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia https://ClinicalTrials.gov/show/NCT01783093 Completed Ohio State University 2013-01-31
NCT01729611 Endothelial Function in Patients With Scleroderma or Cirrhosis With and Without Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01729611 Recruiting The Cleveland Clinic 2021-03-31
NCT01646541 Symptomatic Pulmonary Arterial Hypertension After Mitral Valve Surgery https://ClinicalTrials.gov/show/NCT01646541 Completed Duke University 2014-12-31
NCT01621061 Sleep Related Breathing Disturbances and High Altitude Pulmonary Hypertension in Kyrgyz Highlanders https://ClinicalTrials.gov/show/NCT01621061 Completed University of Zurich 2013-12-31
NCT01607502 Database for Clinical and Anamnestic Data in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01607502 Recruiting Medical University of Graz 2024-07-31
NCT01606839 Noninvasive Measurement of Cardiac Output in Pulmonary Hypertension Using Inert Gas Rebreathing https://ClinicalTrials.gov/show/NCT01606839 Completed Medical University of Graz 2014-02-28
NCT01571713 Side Effects of Pulmonary Hypertension Medications https://ClinicalTrials.gov/show/NCT01571713 Active, not recruiting Stanford University 2020-12-31
NCT01571700 Investigation of Dysynchrony in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01571700 Recruiting Stanford University 2021-12-31
NCT01554774 Non-invasive Assessment of Pulmonary Vascular Resistance in Elderly Patients With Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01554774 Completed Hospital Viamed Valvanera, Spain 2012-07-31
NCT01545180 Observatory: Search for Prognostic Factors of Pulmonary Hypertension Post-capillary in Heart Failure https://ClinicalTrials.gov/show/NCT01545180 Active, not recruiting French Cardiology Society 2018-12-31
NCT01496963 Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia https://ClinicalTrials.gov/show/NCT01496963 Active, not recruiting Ente Ospedaliero Ospedali Galliera 2020-12-31
NCT01491646 Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT01491646 Completed National Jewish Health 2013-10-31
NCT01484899 Smoking: a Risk Factor for Pulmonary Arterial Hypertension? https://ClinicalTrials.gov/show/NCT01484899 Completed University of Zurich 2012-10-31
NCT01443598 Pulmonary Hypertension in Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT01443598 Completed Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires 2011-12-31
NCT01423071 Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of Life https://ClinicalTrials.gov/show/NCT01423071 Completed Wissenschaftliches Institut Bethanien e.V 2015-01-31
NCT01418248 Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease https://ClinicalTrials.gov/show/NCT01418248 Completed Mayo Clinic 2013-08-31
NCT01417338 Registry for Pulmonary Hypertension in China https://ClinicalTrials.gov/show/NCT01417338 Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital 2019-12-31
NCT01406327 Drug Use Investigation for VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension) https://ClinicalTrials.gov/show/NCT01406327 Active, not recruiting GlaxoSmithKline 2020-01-31
NCT01399983 Standardization of 6 Minute Walk Test https://ClinicalTrials.gov/show/NCT01399983 Completed Medical University of Graz 2011-10-31
NCT01389271 Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years https://ClinicalTrials.gov/show/NCT01389271 Completed Bayer 2017-03-08
NCT01387035 Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases https://ClinicalTrials.gov/show/NCT01387035 Recruiting Heidelberg University 2025-12-31
NCT01380054 Pulmonary Hypertension, Quality of Life and Psychosocial Factors https://ClinicalTrials.gov/show/NCT01380054 Completed University Hospital, Montpellier 2016-05-20
NCT01361139 Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD) https://ClinicalTrials.gov/show/NCT01361139 Completed Echosense Ltd. 2014-10-31
NCT01347216 COMPERA / COMPERA-KIDS https://ClinicalTrials.gov/show/NCT01347216 Recruiting Technische Universität Dresden 2020-03-31
NCT04402645 Novel Echocardiographic Methods for Early Identification of Neonates at Risk for Chronic Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT04402645 Recruiting Mount Sinai Hospital, Canada 2020-12-31
NCT04391491 Neuregulin-1 in Patient With Different Forms of Cardiovascular Diseases: a Pilot Study https://ClinicalTrials.gov/show/NCT04391491 Recruiting I.M. Sechenov First Moscow State Medical University 2021-03-01
NCT04293640 Neural Respiratory Drive in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT04293640 Recruiting Golden Jubilee National Hospital 2021-01-31
NCT03310346 Registry of Preterm Newborns With Severe Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03310346 Recruiting University of Colorado, Denver 2023-08-01
NCT04104490 Angiotensin Converting Enzyme (ACE2), Brain, Gut Dysbiosis in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT04104490 Recruiting University of Florida 2020-08-31
NCT04101630 Activity Monitoring in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT04101630 Recruiting Vanderbilt University Medical Center 2023-06-30
NCT04078243 Feasibility of Novel Clinical Trial Infrastructure, Design and Technology for Early Phase Studies in Patients With Pulmonary Hypertension (FIT-PH) https://ClinicalTrials.gov/show/NCT04078243 Recruiting Sheffield Teaching Hospitals NHS Foundation Trust 2021-02-21
NCT04007653 Long-term Outcome After Edoxaban Versus Vitamin K Antagonists for Acute VTE https://ClinicalTrials.gov/show/NCT04007653 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2020-12-31
NCT03974919 Preoperative Pulmonary Systolic Pressure and Outcome After Non-cardiac Surgery:Threshold Analysis https://ClinicalTrials.gov/show/NCT03974919 Completed Peking University First Hospital 2019-06-10
NCT03935178 Evaluating Right Ventricular (RV) Size and Function Using the Upper Valley RV Algorithm and Novel Imaging Modalities https://ClinicalTrials.gov/show/NCT03935178 Recruiting Dartmouth-Hitchcock Medical Center 2020-06-30
NCT03905421 Quality of Life Assessed With the PAH SYMPACT Questionnaire https://ClinicalTrials.gov/show/NCT03905421 Enrolling by invitation Mayo Clinic 2020-03-31
NCT03883048 Analysis of the Severity and Prognosis of Pulmonary Hypertension Associated With Bronchiectasis. https://ClinicalTrials.gov/show/NCT03883048 Recruiting Shanghai Pulmonary Hospital, Shanghai, China 2020-02-01
NCT03786367 Dyspnea in Chronic Thromboembolic Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03786367 Recruiting Queen’s University 2020-03-31
NCT03706820 Exercise Hemodynamics in Patients With Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT03706820 Recruiting Aristotle University Of Thessaloniki 2018-06-01
NCT03667794 Evaluation of Novel Lung Function Parameters in Patients With Pulmonary Hypertension (PH) https://ClinicalTrials.gov/show/NCT03667794 Completed Universitätsmedizin Mannheim 2017-07-31
NCT03581695 Inflammatory Biomarkers of Pediatric Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03581695 Recruiting The Hospital for Sick Children 2019-12-31
NCT03579862 Identification of Heritable CTEPH https://ClinicalTrials.gov/show/NCT03579862 Recruiting Intermountain Health Care, Inc. 2021-12-31
NCT03572036 Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03572036 Active, not recruiting National Institutes of Health Clinical Center (CC) 2021-05-01
NCT03565471 Atrial Septal Defect - Exercise Capacity and Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03565471 Completed University of Aarhus 2019-11-01
NCT03564522 Image-based Multi-scale Modeling Framework of the Cardiopulmonary System: Longitudinal Calibration and Assessment of Therapies in Pediatric Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03564522 Recruiting University of Michigan 2021-02-28
NCT03459716 Endothelial Biomarkers of Systemic Sclerosis-associated Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03459716 Recruiting Louisiana State University Health Sciences Center in New Orleans 2021-04-01
NCT03446339 Pulmonary Hypertension Screening for Rheumatology Patients (SOPHIE) https://ClinicalTrials.gov/show/NCT03446339 Recruiting The University of Hong Kong 2020-08-31
NCT01247116 First-line Bosentan and Sildenafil Combination Therapy for Pulmonary Arterial Hypertension https://ClinicalTrials.gov/show/NCT01247116 Completed University of Calgary 2015-12-31
NCT01203423 Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study https://ClinicalTrials.gov/show/NCT01203423 Completed NICHD Neonatal Research Network 1994-12-31
NCT01135706 Fractal Analysis of the Pulmonary Arterial Tree in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT01135706 Completed Ohio State University 2012-02-29
NCT01076296 A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System https://ClinicalTrials.gov/show/NCT01076296 Completed GE Healthcare 2012-07-31
NCT01062282 Hypertension Study of Ventavis® Inhalation Therapy in the Treatment of Patients With Pulmonary Arterial Hypertension (VENIS) https://ClinicalTrials.gov/show/NCT01062282 Completed Bayer 2009-06-30
NCT01028651 A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension https://ClinicalTrials.gov/show/NCT01028651 Completed United Therapeutics 2013-04-30
NCT01023451 Serum Brain Natriuretic Peptide Levels and Pulmonary Hypertension in Pediatric Sickle Cell Patients https://ClinicalTrials.gov/show/NCT01023451 Completed Akron Children’s Hospital 2013-06-30
NCT00960895 Pulmonary Hypertension in Lymphangioleiomyomatosis https://ClinicalTrials.gov/show/NCT00960895 Completed Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires 2009-12-31
NCT00948012 Exercise-induced Pulmonary Hypertension in Patients With Sickle-cell Anemia https://ClinicalTrials.gov/show/NCT00948012 Completed Federal University of São Paulo 2006-12-31
NCT00946114 To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks https://ClinicalTrials.gov/show/NCT00946114 Completed Pfizer 2009-03-31
NCT00926523 Biomarkers in the Evaluation of Chronic Lung Disease https://ClinicalTrials.gov/show/NCT00926523 Completed Northwell Health 2011-03-31
NCT00909467 Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases https://ClinicalTrials.gov/show/NCT00909467 Completed Medical University of Graz 2011-11-30
NCT00882947 Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH) https://ClinicalTrials.gov/show/NCT00882947 Completed Bayer 2008-09-30
NCT00875940 Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation Analysis https://ClinicalTrials.gov/show/NCT00875940 Completed University of Cincinnati 2009-01-31
NCT00845013 Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00845013 Active, not recruiting University of California, San Francisco 2020-09-30
NCT03876509 Non-invasive Diagnosis of Pulmonary Hypertension by Impedance Cardiography https://ClinicalTrials.gov/show/NCT03876509 Recruiting Medical University of Graz 2020-06-30
NCT01781858 Study on the Clinical Course Of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01781858 Completed University of Padova 2014-05-31
NCT01516398 Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia https://ClinicalTrials.gov/show/NCT01516398 Active, not recruiting Stanford University 2022-01-31
NCT03317314 Cardiopulmonary Interactions in Patients With Heart Failure https://ClinicalTrials.gov/show/NCT03317314 Recruiting Hannover Medical School 2020-06-30
NCT02821156 Study on the Use of Inhaled NO (iNO) https://ClinicalTrials.gov/show/NCT02821156 Completed Air Liquide Santé International 2015-09-30
NCT02580903 Pulmonary Hypertension in Patients With Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT02580903 Recruiting Odense University Hospital 2016-02-29
NCT02117791 Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH ) https://ClinicalTrials.gov/show/NCT02117791 Recruiting Bayer 2022-09-30
NCT01451255 Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging https://ClinicalTrials.gov/show/NCT01451255 Completed Mayo Clinic 2014-06-30
NCT00710177 PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn https://ClinicalTrials.gov/show/NCT00710177 Recruiting Medical College of Wisconsin 2020-12-31
NCT00679224 An Observational Study For Ambrisentan https://ClinicalTrials.gov/show/NCT00679224 Completed GlaxoSmithKline 2013-07-31
NCT00675051 Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00675051 Completed University of California, San Francisco 2009-02-28
NCT00666198 Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan) https://ClinicalTrials.gov/show/NCT00666198 Completed Pfizer 2015-06-30
NCT00625963 The Study Of CT Scans and Echo Parameters in Patients With PAH https://ClinicalTrials.gov/show/NCT00625963 Completed Northwell Health 2008-06-30
NCT00621075 Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans https://ClinicalTrials.gov/show/NCT00621075 Completed Northwell Health 2008-02-29
NCT00614900 Prevalence of Pulmonary Hypertension in COPD Patients https://ClinicalTrials.gov/show/NCT00614900 Completed University of Aarhus 2011-03-31
NCT00575692 Magnetic Resonance Imaging in the Diagnosis of Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00575692 Completed Medical University of Graz 2013-12-31
NCT00566137 Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient https://ClinicalTrials.gov/show/NCT00566137 Completed Northwell Health NA
NCT00527163 Role of Nitric Oxide in Malaria https://ClinicalTrials.gov/show/NCT00527163 Completed National Institutes of Health Clinical Center (CC) NA
NCT00495638 Pulmonary Hypertension, Hypoxia and Sickle Cell Disease https://ClinicalTrials.gov/show/NCT00495638 Completed National Institutes of Health Clinical Center (CC) NA
NCT00820729 Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT00820729 Completed University of Aarhus 2011-03-31
NCT00478296 Pulmonary Hypertension in Trisomy 21 Patients https://ClinicalTrials.gov/show/NCT00478296 Completed Children’s Healthcare of Atlanta 2007-02-28
NCT00464932 Vasoactive Intestinal Peptide in COPD https://ClinicalTrials.gov/show/NCT00464932 Completed Medical University of Vienna NA
NCT00457301 Using Health-related Quality of Life (HRQL) in Routine Clinical Care https://ClinicalTrials.gov/show/NCT00457301 Completed University of Alberta 2007-04-30
NCT00452283 Changes in Eye Pressure and Anterior Chamber Depth With Oral Endothelin Antagonist Therapy https://ClinicalTrials.gov/show/NCT00452283 Completed University of Colorado, Denver 2011-05-31
NCT00377949 Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients https://ClinicalTrials.gov/show/NCT00377949 Completed Georgetown University 2016-01-31
NCT00370214 REVEAL Registryâ„¢: Registry to Evaluate Early And Long-term PAH Disease Management https://ClinicalTrials.gov/show/NCT00370214 Completed Actelion 2012-12-31
NCT00367523 Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria https://ClinicalTrials.gov/show/NCT00367523 Completed National Institutes of Health Clinical Center (CC) NA
NCT00250640 Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years https://ClinicalTrials.gov/show/NCT00250640 Completed Bayer 2012-04-30
NCT00113152 Heart Disease in Sickle Cell Anemia https://ClinicalTrials.gov/show/NCT00113152 Completed National Institutes of Health Clinical Center (CC) NA
NCT00091546 Genetic and Environmental Characteristics of Primary Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00091546 Completed Vanderbilt University 2009-07-31
NCT00005357 Pulmonary Hypertension–Mechanisms and Family Registry https://ClinicalTrials.gov/show/NCT00005357 Completed Vanderbilt University 1999-03-31
NCT00001313 Evaluation of Patients With Known or Suspected Heart Disease https://ClinicalTrials.gov/show/NCT00001313 Completed National Institutes of Health Clinical Center (CC) NA
NCT00000623 Thalassemia (Cooley’s Anemia) Clinical Research Network (TCRN) https://ClinicalTrials.gov/show/NCT00000623 Completed HealthCore-NERI NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04459364 The Prevalence of Pulmonary Hypertension in Patients With COVID-19. https://ClinicalTrials.gov/show/NCT04459364 Recruiting Attgeno AB 2020-07-07
NCT03245268 International BPA Registry https://ClinicalTrials.gov/show/NCT03245268 Active, not recruiting International CTEPH Association 2022-03-31
NCT03185572 Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Hypertension in China https://ClinicalTrials.gov/show/NCT03185572 Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital 2020-12-31
NCT03172429 Cerebral Tissue Oxygenation in Highlanders/Lowlanders https://ClinicalTrials.gov/show/NCT03172429 Completed University of Zurich 2017-08-16
NCT03165656 Right Ventricular Function at Rest in Highlanders/Lowlanders https://ClinicalTrials.gov/show/NCT03165656 Completed University of Zurich 2017-08-16
NCT03165032 Right Ventricular Function During Exercise in Highlanders/Lowlanders https://ClinicalTrials.gov/show/NCT03165032 Completed University of Zurich 2017-08-16
NCT03146702 Turkish Translation of The Emphasis-10 Questionnaire https://ClinicalTrials.gov/show/NCT03146702 Completed Istanbul University 2017-08-31
NCT03039972 Changes in Renal Function and Body Composition in Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03039972 Active, not recruiting University of Giessen 2019-10-07
NCT03039959 Predictive Value of Renal Venous Flow Profiles for Adverse Outcomes in Right Heart Failure https://ClinicalTrials.gov/show/NCT03039959 Completed University of Giessen 2018-03-30
NCT02777957 Predictors of Pulmonary Hypertension in Patients With Advanced Lung Diseases https://ClinicalTrials.gov/show/NCT02777957 Active, not recruiting Silesian Centre for Heart Diseases 2020-04-30
NCT02729844 Neolifes Heart - Pulmonary Hypertension in Preterm Children https://ClinicalTrials.gov/show/NCT02729844 Recruiting University Medical Center Groningen 2020-04-30
NCT02656238 New International CTEPH Database https://ClinicalTrials.gov/show/NCT02656238 Completed International CTEPH Association 2020-01-31
NCT02610660 Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02610660 Recruiting Association for Pediatric Pulmonary Hypertension 2021-12-31
NCT02555137 Early Non-invasive Detection of CTEPH After Pulmonary Embolism https://ClinicalTrials.gov/show/NCT02555137 Active, not recruiting Leiden University Medical Center 2019-11-30
NCT02429284 U.S. CTEPH Registry https://ClinicalTrials.gov/show/NCT02429284 Completed University of California, San Diego 2019-05-31
NCT02265887 The Pan African Pulmonary Hypertension Cohort Study https://ClinicalTrials.gov/show/NCT02265887 Completed University of Cape Town 2013-12-31
NCT02252705 Mexican Registry of Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT02252705 Completed Remehip 2017-12-31
NCT02249923 Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry https://ClinicalTrials.gov/show/NCT02249923 Recruiting University of Colorado, Denver 2020-12-31
NCT02249806 Zürich Pulmonary Hypertension Outcome Assessment Cohort https://ClinicalTrials.gov/show/NCT02249806 Recruiting University of Zurich 2024-09-30
NCT01977014 NIMS- New Implantable Pump in Pulmonary Arterial Hypertension, a Safety Follow up https://ClinicalTrials.gov/show/NCT01977014 Completed NordicInfu Care AB 2016-12-31
NCT04206852 Safety and Efficacy of Balloon Pulmonary Angioplasty in China https://ClinicalTrials.gov/show/NCT04206852 Recruiting Chinese Pulmonary Vascular Disease Research Group 2022-05-11
NCT04145024 Giessen Pulmonary Hypertension Registry and Biobank https://ClinicalTrials.gov/show/NCT04145024 Recruiting University of Giessen 2035-07-15
NCT04071327 Pulmonary Hypertension Association Registry https://ClinicalTrials.gov/show/NCT04071327 Recruiting Pulmonary Hypertension Association, Inc. 2025-10-31
NCT04019600 Screening of Pulmonary Hypertension in Methamphetamine Abusers https://ClinicalTrials.gov/show/NCT04019600 Recruiting The University of Hong Kong 2022-12-22
NCT03959748 DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL https://ClinicalTrials.gov/show/NCT03959748 Recruiting Polish Cardiology Association 2023-02-28
NCT03707561 RUS-registry of PH https://ClinicalTrials.gov/show/NCT03707561 Enrolling by invitation Russian Cardiology Research and Production Center 2020-12-31
NCT03667391 Taiwan Cohort - Chronic ThromboEmbolic Pulmonary Hypertension Registry https://ClinicalTrials.gov/show/NCT03667391 Recruiting National Taiwan University Hospital 2022-01-01
NCT01913457 Measurements and Characterization of Doppler Signals From the Right Chest in Pediatric and Adult Patients https://ClinicalTrials.gov/show/NCT01913457 Recruiting Echosense Ltd. 2020-03-31
NCT03169010 Registration Study for Rare Type of Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03169010 Recruiting China National Center for Cardiovascular Diseases 2022-12-31
NCT03165019 Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders. https://ClinicalTrials.gov/show/NCT03165019 Completed University of Zurich 2017-08-16